BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Konstantinos C. Fragkos, María Claudia Picasso Bouroncle, Shankar Kumar, Lucy Caselton, Alex Menys, Alan Bainbridge, Stuart A. Taylor, Francisco Torrealdea, Tomoko Kumagai, Simona Di Caro, Farooq Rahman, Jane Macnaughtan, Manil D. Chouhan, Shameer Mehta. Serum Scoring and Quantitative Magnetic Resonance Imaging in Intestinal Failure-Associated Liver Disease: A Feasibility StudyNutrients 2020; 12(7): 2151 doi: 10.3390/nu12072151
2
Mariana Verdelho Machado, Helena Cortez-Pinto. Non-alcoholic fatty liver disease: What the clinician needs to knowWorld Journal of Gastroenterology 2014; 20(36): 12956-12980 doi: 10.3748/wjg.v20.i36.12956
3
Laurent Castera, Valérie Vilgrain, Paul Angulo. Noninvasive evaluation of NAFLDNature Reviews Gastroenterology & Hepatology 2013; 10(11): 666 doi: 10.1038/nrgastro.2013.175
4
Hyun-Seok Kim, Laura Rotundo, Neil Kothari, Sung-Hoon Kim, Nikolaos Pyrsopoulos. Vitamin D Is Associated with Severity and Mortality of Non-alcoholic Fatty Liver Disease: A US Population-based StudyJournal of Clinical and Translational Hepatology 2017; (XX): XX doi: 10.14218/JCTH.2017.00025
5
Long Wang, Mian Li, Zhiyun Zhao, Min Xu, Jieli Lu, Tiange Wang, Yuhong Chen, Shuangyuan Wang, Meng Dai, Yanan Hou, Xueyan Wu, Lina Ma, Lin Li, Shanshan Liu, Weiqing Wang, Yu Xu, Yufang Bi, Guang Ning. Ideal Cardiovascular Health Is Inversely Associated with Nonalcoholic Fatty Liver Disease: A Prospective AnalysisThe American Journal of Medicine 2018; 131(12): 1515.e1 doi: 10.1016/j.amjmed.2018.07.011
6
Sara Saki, Nader Saki, Hossein Poustchi, Reza Malekzadeh. Assessment of Genetic Aspects of Non-alcoholic Fatty Liver and Premature Cardiovascular EventsMiddle East Journal of Digestive Diseases 2020; 12(2): 65 doi: 10.34172/mejdd.2020.166
7
H. Perazzo, M. Munteanu, Y. Ngo, P. Lebray, N. Seurat, F. Rutka, M. Couteau, S. Jacqueminet, P. Giral, D. Monneret, F. Imbert-Bismut, V. Ratziu, A. Hartemann-Huertier, C. Housset, T. Poynard. Prognostic value of liver fibrosis and steatosis biomarkers in type-2 diabetes and dyslipidaemiaAlimentary Pharmacology & Therapeutics 2014; 40(9): 1081 doi: 10.1111/apt.12946
8
Giorgio Sesti, Teresa Vanessa Fiorentino, Franco Arturi, Maria Perticone, Angela Sciacqua, Francesco Perticone, Claudia Miele. Association between Noninvasive Fibrosis Markers and Chronic Kidney Disease among Adults with Nonalcoholic Fatty Liver DiseasePLoS ONE 2014; 9(2): e88569 doi: 10.1371/journal.pone.0088569
9
Atilla Engin. Obesity and LipotoxicityAdvances in Experimental Medicine and Biology 2017; 960: 443 doi: 10.1007/978-3-319-48382-5_19
10
Karen L. Thomsen, Lionel Hebbard, Emilie Glavind, Andrew Clouston, Hendrik Vilstrup, Jacob George, Henning Grønbaek. Non-alcoholic steatohepatitis weakens the acute phase response to endotoxin in ratsLiver International 2014; 34(10): 1584 doi: 10.1111/liv.12547
11
Bo Kyung Koo, Donghee Kim, Sae Kyung Joo, Jung Ho Kim, Mee Soo Chang, Byeong Gwan Kim, Kook Lae Lee, Won Kim. Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosisJournal of Hepatology 2017; 66(1): 123 doi: 10.1016/j.jhep.2016.08.019
12
Sheila M. Grecian, Stela McLachlan, Jonathan A. Fallowfield, Patrick K. A. Kearns, Peter C. Hayes, Neil I. Guha, Joanne R. Morling, Stephen Glancy, Rachel M. Williamson, Rebecca M. Reynolds, Brian M. Frier, Nicola N. Zammitt, Jackie F. Price, Mark W. J. Strachan. Non‐invasive risk scores do not reliably identify future cirrhosis or hepatocellular carcinoma in Type 2 diabetes: The Edinburgh type 2 diabetes studyLiver International 2020;  doi: 10.1111/liv.14590
13
Katharina Schwarzkopf, Joerg Bojunga, Sabrina Rüschenbaum, Yolanda Martinez, Marcus M. Mücke, Florian Seeger, Fabian Schoelzel, Stefan Zeuzem, Mireen Friedrich‐Rust, Christian M. Lange. Use of Antiplatelet Agents Is Inversely Associated With Liver Fibrosis in Patients With Cardiovascular DiseaseHepatology Communications 2018; 2(12): 1601 doi: 10.1002/hep4.1254
14
Sun Hwa Lee, Seong Jong Yun, Dong Hyeon Kim, Hyeon Hwan Jo, Yong Sung Park. Severity of nonalcoholic fatty liver disease on sonography and risk of coronary heart diseaseJournal of Clinical Ultrasound 2017; 45(7): 391 doi: 10.1002/jcu.22472
15
Fabio Nascimbeni, Stefano Ballestri, Mariana Verdelho Machado, Alessandro Mantovani, Helena Cortez-Pinto, Giovanni Targher, Amedeo Lonardo. Clinical relevance of liver histopathology and different histological classifications of NASH in adultsExpert Review of Gastroenterology & Hepatology 2018; 12(4): 351 doi: 10.1080/17474124.2018.1415756
16
Marc–Emmanuel Dumas, James Kinross, Jeremy K. Nicholson. Metabolic Phenotyping and Systems Biology Approaches to Understanding Metabolic Syndrome and Fatty Liver DiseaseGastroenterology 2014; 146(1): 46 doi: 10.1053/j.gastro.2013.11.001
17
K.H. Williams, A.J. Viera de Ribeiro, E. Prakoso, A.S. Veillard, N.A. Shackel, Y. Bu, B. Brooks, E. Cavanagh, J. Raleigh, S.V. McLennan, G.W. McCaughan, W.W. Bachovchin, F.M. Keane, A. Zekry, S.M. Twigg, M.D. Gorrell. Lower serum fibroblast activation protein shows promise in the exclusion of clinically significant liver fibrosis due to non-alcoholic fatty liver disease in diabetes and obesityDiabetes Research and Clinical Practice 2015; 108(3): 466 doi: 10.1016/j.diabres.2015.02.024
18
Pegah Golabi, Maria Stepanova, Huong T Pham, Rebecca Cable, Nila Rafiq, Haley Bush, Trevor Gogoll, Zobair M Younossi. Non-alcoholic steatofibrosis (NASF) can independently predict mortality in patients with non-alcoholic fatty liver disease (NAFLD)BMJ Open Gastroenterology 2018; 5(1): e000198 doi: 10.1136/bmjgast-2018-000198
19
Alessandro Mantovani, Eleonora Scorletti, Antonella Mosca, Anna Alisi, Christopher D. Byrne, Giovanni Targher. Complications, morbidity and mortality of nonalcoholic fatty liver diseaseMetabolism 2020; : 154170 doi: 10.1016/j.metabol.2020.154170
20
Panyavee Pitisuttithum, Wah-Kheong Chan, George Boon-Bee Goh, Jian-Gao Fan, Myeong Jun Song, Phunchai Charatcharoenwitthaya, Ajay Duseja, Yock-Young Dan, Kento Imajo, Atsushi Nakajima, Khek-Yu Ho, Khean-Lee Goh, Vincent Wai-Sun Wong, Sombat Treeprasertsuk. Gamma-glutamyl transferase and cardiovascular risk in nonalcoholic fatty liver disease: The Gut and Obesity Asia initiativeWorld Journal of Gastroenterology 2020; 26(19): 2415 doi: 10.3748/wjg.v26.i19.2415
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
21
Suzanne E. Mahady, Petra Macaskill, Jonathan C. Craig, Grace L.H. Wong, Winnie C.W. Chu, Henry L.Y. Chan, Jacob George, Vincent W.S. Wong. Diagnostic Accuracy of Noninvasive Fibrosis Scores in a Population of Individuals With a Low Prevalence of FibrosisClinical Gastroenterology and Hepatology 2017; 15(9): 1453 doi: 10.1016/j.cgh.2017.02.031
22
Hilmar K Lückhoff, Frederik C Kruger, Maritha J Kotze. Composite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countriesWorld Journal of Hepatology 2015; 7(9): 1192-1208 doi: 10.4254/wjh.v7.i9.1192
23
Angelina Zhyvotovska, Denis Yusupov, Samy I. McFarlane. Dyslipidemia2019;  doi: 10.5772/intechopen.85094
24
Elif Dincses, Yusuf Yilmaz. Diagnostic usefulness of FibroMeter VCTE for hepatic fibrosis in patients with nonalcoholic fatty liver diseaseEuropean Journal of Gastroenterology & Hepatology 2015; 27(10): 1149 doi: 10.1097/MEG.0000000000000409
25
Daniel L. Motola, Peter Caravan, Raymond T. Chung, Bryan C. Fuchs. Noninvasive Biomarkers of Liver Fibrosis: Clinical Applications and Future DirectionsCurrent Pathobiology Reports 2014; 2(4): 245 doi: 10.1007/s40139-014-0061-z
26
Changzhou Cai, Xin Song, Yishu Chen, Xueyang Chen, Chaohui Yu. Relationship between relative skeletal muscle mass and nonalcoholic fatty liver disease: a systematic review and meta-analysisHepatology International 2020; 14(1): 115 doi: 10.1007/s12072-019-09964-1
27
Hiroshi Ishiba, Yoshio Sumida, Seita Kataoka, Masaaki Kuroda, Satoshi Akabame, Kiichiro Tomiyasu, Muhei Tanaka, Masahiro Arai, Hiroyoshi Taketani, Yuya Seko, Akira Okajima, Tasuku Hara, Atsushi Umemura, Taichiro Nishikawa, Kanji Yamaguchi, Michihisa Moriguchi, Hironori Mitsuyoshi, Kohichiroh Yasui, Yoshito Itoh. Association of coronary artery calcification with liver fibrosis in Japanese patients with non-alcoholic fatty liver diseaseHepatology Research 2016; 46(11): 1107 doi: 10.1111/hepr.12665
28
Wei-Jen Ting, Wei-Wen Kuo, Dennis Hsieh, Yu-Lan Yeh, Cecilia-Hsuan Day, Ya-Hui Chen, Ray-Jade Chen, Viswanadha Padma, Yi-Hsing Chen, Chih-Yang Huang. Heat Killed Lactobacillus reuteri GMNL-263 Reduces Fibrosis Effects on the Liver and Heart in High Fat Diet-Hamsters via TGF-β SuppressionInternational Journal of Molecular Sciences 2015; 16(10): 25881 doi: 10.3390/ijms161025881
29
Zaki A. Sherif, Armana Saeed, Shima Ghavimi, Seyed-Mehdi Nouraie, Adeyinka O. Laiyemo, Hassan Brim, Hassan Ashktorab. Global Epidemiology of Nonalcoholic Fatty Liver Disease and Perspectives on US Minority PopulationsDigestive Diseases and Sciences 2016; 61(5): 1214 doi: 10.1007/s10620-016-4143-0
30
Trace Heavener, Ahmed Memon, Shamyal Khan, Sam Davis, Lauren Sager, Sharon DeMorrow, Mark Jeffries. Testing the ability of the nonalcoholic fatty liver disease fibrosis score to predict 1-year all-cause hospital admissionBaylor University Medical Center Proceedings 2019; 32(1): 26 doi: 10.1080/08998280.2018.1543227
31
Giorgio Sesti, Angela Sciacqua, Teresa Vanessa Fiorentino, Maria Perticone, Elena Succurro, Francesco Perticone, Anna Alisi. Association between Noninvasive Fibrosis Markers and Cardio-Vascular Organ Damage among Adults with Hepatic SteatosisPLoS ONE 2014; 9(8): e104941 doi: 10.1371/journal.pone.0104941
32
Panyavee Pitisuttithum, Wah-Kheong Chan, George Boon-Bee Goh, Jian-Gao Fan, Myeong Jun Song, Phunchai Charatcharoenwitthaya, Ajay Duseja, Yock-Young Dan, Kento Imajo, Atsushi Nakajima, Khek-Yu Ho, Khean-Lee Goh, Vincent Wai-Sun Wong, Sombat Treeprasertsuk. Gamma-glutamyl transferase and cardiovascular risk in nonalcoholic fatty liver disease: The Gut and Obesity Asia initiativeWorld Journal of Gastroenterology 2020; 26(19): 2416-2426 doi: 10.3748/wjg.v26.i19.2416
33
Jun L. Chin, Michael Pavlides, Ahmad Moolla, John D. Ryan. Non-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy?Frontiers in Pharmacology 2016; 7 doi: 10.3389/fphar.2016.00159
34
Tetsuya Takahashi, Tetsu Watanabe, Tetsuro Shishido, Ken Watanabe, Takayuki Sugai, Taku Toshima, Daisuke Kinoshita, Miyuki Yokoyama, Harutoshi Tamura, Satoshi Nishiyama, Takanori Arimoto, Hiroki Takahashi, Tamon Yamanaka, Takuya Miyamoto, Isao Kubota. The impact of non-alcoholic fatty liver disease fibrosis score on cardiac prognosis in patients with chronic heart failureHeart and Vessels 2018; 33(7): 733 doi: 10.1007/s00380-017-1113-1
35
Federico Salomone, Agnieszka Micek, Justyna Godos. Simple Scores of Fibrosis and Mortality in Patients with NAFLD: A Systematic Review with Meta-AnalysisJournal of Clinical Medicine 2018; 7(8): 219 doi: 10.3390/jcm7080219
36
Antonio De Vincentis, Luisa Costanzo, Umberto Vespasiani-Gentilucci, Antonio Picardi, Stefania Bandinelli, Luigi Ferrucci, Raffaele Antonelli Incalzi, Claudio Pedone. Association between non-invasive liver fibrosis scores and occurrence of health adverse outcomes in older peopleDigestive and Liver Disease 2019; 51(9): 1330 doi: 10.1016/j.dld.2019.01.017
37
Marta Iruarrizaga-Lejarreta, Fernando Bril, Mazen Noureddin, Pablo Ortiz, Shelly C. Lu, José M. Mato, Cristina Alonso. Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease2019; : 423 doi: 10.1007/978-3-030-11748-1_16
38
Mark CC Cheah, Arthur J McCullough, George Boon-Bee Goh. Current Modalities of Fibrosis Assessment in Non-alcoholic Fatty Liver DiseaseJournal of Clinical and Translational Hepatology 2017; (XX): 1 doi: 10.14218/JCTH.2017.00009
39
Diego García-Compeán, Jesús Zacarías Villarreal-Pérez, Manuel Enrique de la O. Cavazos, Fernando Javier Lavalle-Gonzalez, Omar David Borjas-Almaguer, Angel Noé Del Cueto-Aguilera, José Alberto González-González, Consuelo Treviño-Garza, Lourdes Huerta-Pérez, Héctor Jesús Maldonado-Garza. Prevalence of liver fibrosis in an unselected general population with high prevalence of obesity and diabetes mellitus. Time for screening?Annals of Hepatology 2020; 19(3): 258 doi: 10.1016/j.aohep.2020.01.003
40
Serkan Dogan, Mehmet Celikbilek, Yunus K. Yilmaz, Savas Sarikaya, Gokmen Zararsiz, Halil I. Serin, Elif Borekci, Lütfi Akyol, Ilyas Pirti, Sena E. Davarci. Association between liver fibrosis and coronary heart disease risk in patients with nonalcoholic fatty liver diseaseEuropean Journal of Gastroenterology & Hepatology 2015; 27(3): 298 doi: 10.1097/MEG.0000000000000286
41
Lisa C. Adams, Falk Lübbe, Keno Bressem, Moritz Wagner, Bernd Hamm, Marcus R. Makowski, Pavel Strnad. Non-alcoholic fatty liver disease in underweight patients with inflammatory bowel disease: A case-control studyPLOS ONE 2018; 13(11): e0206450 doi: 10.1371/journal.pone.0206450
42
Hannes Hagström, Patrik Nasr, Mattias Ekstedt, Per Stål, Rolf Hultcrantz, Stergios Kechagias. Accuracy of Noninvasive Scoring Systems in Assessing Risk of Death and Liver-Related Endpoints in Patients With Nonalcoholic Fatty Liver DiseaseClinical Gastroenterology and Hepatology 2019; 17(6): 1148 doi: 10.1016/j.cgh.2018.11.030
43
Meng-Hsuan Hsieh, Kuan-Ta Wu, Yi-Yu Chen, Jeng-Fu Yang, Wen-Yi Lin, Ning-Chia Chang, Chia-Yi Lin, Chao-Kuan Huang, Chao-Ling Wang, Hung-Yi Chuang, Shu-Ching Lin, Yu-Kuei Hsu, Yi-Shan Tsai, Wan-Long Chuang, Ming-Lung Yu, Chia-Yen Dai. Higher NAFLD fibrosis score is associated with impaired eGFRJournal of the Formosan Medical Association 2020; 119(1): 496 doi: 10.1016/j.jfma.2019.07.007
44
Per Stål. Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significanceWorld Journal of Gastroenterology 2015; 21(39): 11077-11087 doi: 10.3748/wjg.v21.i39.11077
45
Aynur Unalp-Arida, Constance E. Ruhl. Liver fibrosis scores predict liver disease mortality in the United States populationHepatology 2017; 66(1): 84 doi: 10.1002/hep.29113
46
Vlad Ratziu. Clinical Dilemmas in Non-Alcoholic Fatty Liver Disease2016; : 111 doi: 10.1002/9781118924938.ch13
47
Muharrem Bayrak. Non-invasive diagnosis of nonalcoholic fatty liver disease: impact of age and other risk factorsThe Aging Male 2020; : 1 doi: 10.1080/13685538.2020.1763293
48
Cory M. Fielding, Paul Angulo. Hepatic Steatosis and Steatohepatitis: Are they Really Two Distinct Entities?Current Hepatology Reports 2014; 13(2): 151 doi: 10.1007/s11901-014-0227-5
49
John B. Dixon. Surgical Management of Obesity in Patients with Morbid Obesity and Nonalcoholic Fatty Liver DiseaseClinics in Liver Disease 2014; 18(1): 129 doi: 10.1016/j.cld.2013.09.011
50
Alessandra Gentili, Giulia Daviddi, Stefano De Vuono, Maria Anastasia Ricci, Francesco Di Filippo, Abdalkader Alaeddin, Massimo R. Mannarino, Marcello Boni, Gaetano Vaudo, Graziana Lupattelli. Non-alcoholic fatty liver disease fibrosis score and preclinical vascular damage in morbidly obese patientsDigestive and Liver Disease 2016; 48(8): 904 doi: 10.1016/j.dld.2016.04.004
51
Zobair M. Younossi, Linda Henry. Are Noninvasive Scoring Systems for Persons With Chronic Liver Disease Ready for Prime Time?Gastroenterology 2020; 158(1): 40 doi: 10.1053/j.gastro.2019.11.024
52
Veeravich Jaruvongvanich, Karn Wijarnpreecha, Patompong Ungprasert. The utility of NAFLD fibrosis score for prediction of mortality among patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of cohort studyClinics and Research in Hepatology and Gastroenterology 2017; 41(6): 629 doi: 10.1016/j.clinre.2017.03.010
53
M. Del Ben, L. Polimeni, F. Baratta, S. Bartimoccia, R. Carnevale, L. Loffredo, P. Pignatelli, F. Violi, F. Angelico. Serum Cytokeratin-18 Is Associated with NOX2-Generated Oxidative Stress in Patients with Nonalcoholic Fatty LiverInternational Journal of Hepatology 2014; 2014: 1 doi: 10.1155/2014/784985
54
Guilherme M. Campos, David A. Lanning. Bariatric surgery for nonalcoholic fatty liver disease in adolescents with severe obesitySurgery for Obesity and Related Diseases 2015; 11(2): 449 doi: 10.1016/j.soard.2014.12.015
55
G. E. Rojtberg, O. O. Sharkhun. Non-alcoholic fatty liver disease and the myocardial remodeling: the role of insulin resistance in the hepatocardial association developmentExperimental and Clinical Gastroenterology 2020; 174(5): 47 doi: 10.31146/1682-8658-ecg-177-5-47-52
56
Evgin Goceri, Zarine K. Shah, Rick Layman, Xia Jiang, Metin N. Gurcan. Quantification of liver fat: A comprehensive reviewComputers in Biology and Medicine 2016; 71: 174 doi: 10.1016/j.compbiomed.2016.02.013
57
Zong Jie Koh, Hrishikesh Pandurang Salgaonkar, Wei Jie Jonathan Lee, Guo Wei Kim, Chun Hai Tan, Anton Cheng, Davide Lomanto, Jimmy Bok Yan So, Yock Young Dan, Asim Shabbir. Improvement in Non-alcoholic Fatty Liver Disease Score Correlates with Weight Loss in Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy: a Two-Centre Study from an Asian CohortObesity Surgery 2019; 29(3): 862 doi: 10.1007/s11695-018-3581-5
58
Shanwen Charleen Yeo, Weijie Marc Ong, Kui Sing Anton Cheng, Chun Hai Tan. Weight Loss After Bariatric Surgery Predicts an Improvement in the Non-alcoholic Fatty Liver Disease (NAFLD) Fibrosis ScoreObesity Surgery 2019; 29(4): 1295 doi: 10.1007/s11695-018-03676-5